We are live on ! Find out more
BDSX icon

Biodesix
BDSX

27 hedge funds and large institutions have $6.04M invested in Biodesix in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more call options, than puts

Call options by funds: $78K | Put options by funds: $55K

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

1% more capital invested

Capital invested by funds: $5.99M → $6.04M (+$51.8K)

0.13% more ownership

Funds ownership: 0.47% → 0.59% (+0.13%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

25% less funds holding

Funds holding: 36 → 27 (-9)

69% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 13

Holders
27
Holders Change
-9
Holders Change %
-25%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
9
Reduced
8
Closed
13
Calls
$78K
Puts
$55K
Net Calls
+$23K
Net Calls Change
–

Top Buyers

1
BC
Birchview Capital
Vermont
+$1.08M
2
EIM
Essex Investment Management
Massachusetts
+$729K
3
Wells Fargo
Wells Fargo
California
+$427K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$115K
5
BCM
Bridgeway Capital Management
Texas
+$96.4K

Top Sellers

1
FAM
Fred Alger Management
New York
-$215K
2
CC
Chicago Capital
Illinois
-$38K
3
E
Ergoteles
New York
-$36K
4
Morgan Stanley
Morgan Stanley
New York
-$32.6K
5
Northern Trust
Northern Trust
Illinois
-$22.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Birchview Capital
Vermont
$3.01M +$1.08M +27,933 +31%
Wells Fargo
2
Wells Fargo
California
$984K +$427K +11,069 +40%
EIM
3
Essex Investment Management
Massachusetts
$480K +$729K +18,901 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$305K +$115K +2,983 +33%
CC
5
Cannell & Co
New York
$261K – – –
ECM
6
Endurant Capital Management
California
$165K -$1.2K -31 -0.5%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$157K +$52.6K +1,365 +28%
Millennium Management
8
Millennium Management
New York
$150K +$1.39K +36 +0.6%
BCM
9
Bridgeway Capital Management
Texas
$127K +$96.4K +2,500 +100%
Renaissance Technologies
10
Renaissance Technologies
New York
$72K +$578 +15 +0.5%
Morgan Stanley
11
Morgan Stanley
New York
$71K -$32.6K -846 -23%
AF
12
Allworth Financial
California
$71K – – –
BlackRock
13
BlackRock
New York
$50K +$3.97K +103 +6%
Citadel Advisors
14
Citadel Advisors
Florida
$40K +$7.75K +201 +15%
Northern Trust
15
Northern Trust
Illinois
$20K -$22.9K -595 -43%
CL
16
CPWM LLC
Washington
$20K – – –
Qube Research & Technologies (QRT)
17
Qube Research & Technologies (QRT)
United Kingdom
$17K -$3.97K -103 -13%
State Street
18
State Street
Massachusetts
$16K -$9.64K -250 -28%
Verition Fund Management
19
Verition Fund Management
Connecticut
$14K – – –
CCA
20
Column Capital Advisors
Indiana
$7K – – –
BNP Paribas Financial Markets
21
BNP Paribas Financial Markets
France
$3.81K +$5.79K +150 New
Osaic Holdings
22
Osaic Holdings
Arizona
$1K -$424 -11 -18%
FAM
23
Fred Alger Management
New York
– -$215K -6,545 Closed
CC
24
Chicago Capital
Illinois
– -$38K -1,168 Closed
E
25
Ergoteles
New York
– -$36K -1,111 Closed
1
2

BDSX Hedge Fund Activity: Q3 2022 in Review

27 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q3 2022, worth a combined $6.04M — up 0.87% from $5.99M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BDSX and 4 opened new positions — a net loss of 9 holders — while 8 trimmed existing stakes and 9 added.

The largest buyer was Birchview Capital, adding an estimated $1.08M. The largest seller was Fred Alger Management, exiting entirely with an estimated $215K sold.

  • 27 institutional investors held Biodesix (BDSX) as of Q3 2022, down from 36 in Q2 2022.
  • Funds reported $6.04M of Biodesix stock for Q3 2022, up 0.87% quarter-over-quarter.
  • 4 funds opened new Biodesix positions in Q3 2022 and 13 closed out, a net change of -9 holders.
  • The largest Biodesix buyer in Q3 2022 was Birchview Capital, an estimated $1.08M added.
  • The largest Biodesix seller in Q3 2022 was Fred Alger Management, an estimated $215K sold.

Based on aggregated 13F filings for Q3 2022.